Corcept Therapeutics

CORT

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitiga …

Insider trades and stock quote 2023-2025

All insider trades at Corcept Therapeutics

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
4/10/2025 SellSwisher, Daniel N Jr Director $70.2 $154,484
4/1/2025 SellBelanoff, Joseph K. Chief Executive Officer $114.7 $40,149
4/1/2025 SellGuyer, William Chief Development Officer $114.5 $77,639
4/1/2025 SellLyon, Joseph Douglas Officer $114.5 $74,443
4/1/2025 SellMaduck, Sean Officer $114.5 $67,584
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)